On August 26, 2025, as part of the official visit of His Majesty King Abdullah II bin Al-Hussein of Jordan to Kazakhstan, the National Holding “QazBioPharm” was visited by a delegation of the Jordanian company DADvet.

Representing the Jordanian company at the negotiations were:

Khaled Harb (Mr. Khaled Abedalhameed Mahmoud Harb), General Director;

Khaled Sharaf (Mr. Khaled Abdel Monem Faisal Sharaf), Business Development Director;

Shakeeb Saleh (Mr. Shakeeb Mohd Rashiq Shakeeb Saleh), Member of the Board of Directors.

The meeting was also attended by Olzhas Raev, Economic Affairs Advisor at the Embassy of the Republic of Kazakhstan in Jordan.

On behalf of the Holding, the delegation was welcomed by:

Aralbek Rsaliyev, Acting General Director;

Daulet Aldyngurov, Deputy General Director for Biological Safety;

Kairzhan Baizhanov, Director of the Marketing and Product Promotion Department;

Yerkebulan Saparbekov, Director of the International Cooperation and Investment Attraction Department;

Madi Kenesbek, Chief Manager of the Marketing and Product Promotion Department.

During the visit, the guests were introduced to the activities of the Holding and its subsidiaries, and toured the Immunochemistry and Immunobiotechnology Laboratory, as well as the Applied Genetics Laboratory of the National Center for Biotechnology. Special attention was given to the innovative CAR-T cell therapy technology in the field of oncohematology.

The parties also held a roundtable discussion, where they reviewed prospects for bilateral cooperation, issues related to product export and registration, as well as the development of joint scientific and technical projects.

The visit became a logical continuation of earlier negotiations and reaffirmed the mutual interest of both sides in strengthening cooperation in the pharmaceutical sector.